Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: Evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 728-739

  Fidel Jr , Paul L ^a   Ginsburg, Kenneth A ^b   Cutright, Jessica L ^b   Wolf, Norbert A ^b   Leaman, Deborah ^b   Dunlap, Kathleen ^b   Sobel, Jack D ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ANTIGEN; CYTOKINE; ESTRADIOL; GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PHYTOHEMAGGLUTININ; POTASSIUM HYDROXIDE; TETANUS TOXOID;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTRAVAGINAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; PRIORITY JOURNAL; RECURRENT INFECTION; SKIN TEST; SUPPOSITORY; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINA SECRETION; VAGINA SMEAR;

EID: 16944363805     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514097     Document Type: Article

References (13)

1. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann NY Acad Sci 1988;544:547-57.
2. Lynch ME, Sobel JD, Fidel PL Jr. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis. J Med Vet Mycol 1996;34:337-9.
3. Klein RS, Harris CA, Small CB, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-7.
4. Macher AM. The pathology of AIDS. Public Health Rep 1988;103:246-50.
5. Clift RA. Candidiasis in the transplant patient. Am S Med 1984; 77(suppl 4D):34-8.
6. Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis 1971;123:371-7.
7. Fong IW, McCleary P, Read S. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol 1992; 166:887-90.
8. Fidel PL Jr, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J Infect Dis 1993;168:1458-65.
9. Syverson RA, Buckley H, Gibian J, Ryan JM. Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol 1979;134:624-7.
10. Witkin SS. Inhibition of Candida-induced lymphocyte proliferation by antibody to Candida albicans. Obstet Gynecol 1986;68:696-9.
11. Witkin SS, Hirsch J, Ledger WJ. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol 1986;155:790-5.
12. Hobbs JR, Briden D, Davidson F, Kahan M, Oates JK. Immunological aspects of candidal vaginitis. Proc R Soc Med 1977;70:11-4.
13. Romani L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun 1991;59:4647-54.